RegisPetMed Express

Regis vs PetMed Express

Regis Corporation operates salon brands across thousands of locations navigating a franchise transition, while PetMed Express sells pet medications online competing against vet clinics and Amazon. Bot...

Investment Analysis

Pros

  • Regis Corp. showed revenue growth to $210.13 million in fiscal 2025, increasing 3.52% year-over-year, indicating a positive sales momentum.
  • The company has a low price-to-earnings ratio of 0.61, suggesting potential undervaluation relative to earnings.
  • Analysts project strong long-term price appreciation for Regis stock, with forecasts exceeding 500% growth by 2040-2050.

Considerations

  • Recent technical signals indicate a negative short- and long-term outlook with ongoing sell signals and potential for further price declines.
  • Regis exhibits higher than average stock price volatility with a beta of 1.47, exposing investors to increased market risk.
  • Revenue has shown some volatility with a 4.88% decline in the last twelve months and inconsistent quarterly growth trends.

Pros

  • PetMed Express offers a high dividend yield near 14%, providing strong income potential for investors.
  • The company operates in the niche pet pharmaceutical market, catering to growing direct-to-consumer demand for pet medications and health products.
  • Recent leadership additions to the board signal potential governance improvements and strategic direction clarity.

Considerations

  • PetMed Express has a high price-to-earnings ratio around 57, indicating expensive valuation relative to earnings.
  • The stock price has experienced a wide 52-week range, suggesting considerable recent price instability and market uncertainty.
  • The company’s smaller market cap and employee base highlight potential limitations in scale and operational leverage compared to larger competitors.

Buy RGS or PETS in Nemo

Nemo Logo Fade
🆓

Zero Commission

Trade stocks, ETFs, and more with zero commission. Keep more of your returns.

🔒

Trusted & Regulated

Part of Exinity Group 2015, serving over a million customers globally.

💰

6% Interest on Cash

Earn 6% AER on uninvested cash with daily interest payments.

Frequently asked questions

RGS
RGS$24.56
vs
PETS
PETS$2.33